FindTrial
Sign In

An observational study of Meridian Activation Remedy System on motor symptoms in Parkinson’s disease

An observational study of Meridian Activation Remedy System on motor symptoms in Parkinson’s disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0005986
Enrollment
13
Registered
2021-03-11
Start date
2021-03-09
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Daejeon Korean Medicine Hospital of Daejeon University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age = 20 years 2. Patients diagnosed with Parkinson's disease according to the UK Parkinson's Diseases Society Brain Bank criteria and have motor symptoms(tremor, rigidity, bradykinesia, postural instability) 3. Hoehn and Yahr scale = stage 3 4. Patients who have voluntarily agreed to the written consent of the patients or the legal representative in the clinical research agreement 5. Mini Mental State Examination-K(MMSE-K) = 24

Exclusion criteria

Exclusion criteria: 1. Patients who diagnosed with or suspected of Parkinson's Plus. 2. In case of general unstable medical condition (according to the standard work instructions, the research doctor judges based on the results of vital signs, clinical pathology) 3. Those whose AST or ALT blood level is 3 times or more than the normal upper limit 4. Patients under treatment for uncontrolled hypertension(over 160/100 mmHg) 5. Having history of neuropsychiatric disorder 6. Having a allergy reaction on stainless steel needle and metals 7. Participating other clinical researchs for a least 4 weeks 8. Those who the researcher deems unsuitable for this study 9. Expectant mother, lactating woman, fertile woman

Design outcomes

Primary

MeasureTime frame
UPDRS(Unified Parkinson's Disease Rating Scale) III;UPDRS(Unified Parkinson's Disease Rating Scale) II—

Secondary

MeasureTime frame
fNIRS(functional Near-Infrared Spectroscopy);GAITRite;TUG(Timed Up and Go);BBS(Berg Balance Scale);FES(Fall Efficacy Scale);PDQL(Parkinson's Disease Quality of Life Questionnaire);EQ-5D(Euro-QoL-5D);Iris images;10M Walking Test;UPDRS(Unified Parkinson's Disease Rating Scale) I;UPDRS(Unified Parkinson's Disease Rating Scale) IV;Economic evaluation;PIS Report—

Countries

Korea, Republic of

Contacts

Public ContactInWoo Choi

Daejeon Korean Medicine Hospital of Daejeon University

dlsdn7461@naver.com+82-42-470-9131

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026